Isto gains cash boost for neocartilage allograft:
This article was originally published in Clinica
Isto Technologies has gained a $750,000 US grant to fund the continued development of a tissue-engineered neocartilage allograft for the surgical repair of focal articular cartilage defects in the knee and other joints. The award from the National Institute of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, will fund research to assess the allograft in sheep. The St Louis, Missouri firm estimates that the market potential for a "superior" cartilage repair technology exceeds $1bn in the US alone. Isto is also developing an osteochondral allograft that may be more suitable for osteoarthritic lesions.